Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients

Paul N. Harden^*, David S. Game, Birgit Sawitzki, Jeroen B. Van der Net, Joanna Hester, Andrew Bushell, Fadi Issa, Matthew O. Brook, Alaa Alzhrani, Stephan Schlickeiser, Cristiano Scotta, William Petchey, Mathias Streitz, Gilles Blancho, Quizhi Tang, James Markmann, Robert I. Lechler, Ian S.D. Roberts, Peter J. Friend, Rachel HiltonEdward K. Geissler, Kathryn J. Wood, Giovanna Lombardi

^*Corresponding author for this work

Peter Gorer Department of Immunobiology
Principal's Office

Oxford University Hospitals Trust
GSTT Guy's and St Thomas' NHS Foundation Trust
Institute for Radiology, CCM
University of Oxford
University of Nantes
University of California, San Francisco
Massachusetts General Hospital
University Regensburg

Research output: Contribution to journal › Article › peer-review

81 Citations (Scopus)

Sort by
Weight
Alphabetically

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients

Fingerprint

Medicine and Dentistry